Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amarin Corporation PLC

AMRN
Current price
0.73 USD -0.028 USD (-3.68%)
Last closed 0.76 USD
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NASDAQ
Capitalization 299 975 456 USD
Yield for 12 month -38.65 %
1Y
3Y
5Y
10Y
15Y
AMRN
21.11.2021 - 28.11.2021

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: Iconic Offices, The Greenway, Dublin, Ireland, 112-114

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1 USD

P/E ratio

Dividend Yield

Current Year

+308 100 608 USD

Last Year

+369 193 000 USD

Current Quarter

+56 486 727 USD

Last Quarter

+75 362 931 USD

Current Year

+202 586 206 USD

Last Year

+242 484 000 USD

Current Quarter

+31 124 218 USD

Last Quarter

+44 776 150 USD

Key Figures AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -22 922 000 USD
Operating Margin TTM -24.03 %
PE Ratio
Return On Assets TTM -1.96 %
PEG Ratio -1.74
Return On Equity TTM -9.31 %
Wall Street Target Price 1 USD
Revenue TTM 277 455 008 USD
Book Value 1.33 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -34.3 %
Dividend Yield
Gross Profit TTM 260 562 000 USD
Earnings per share -0.13 USD
Diluted Eps TTM -0.13 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -94.2 %
Profit Margin -18.96 %

Dividend Analytics AMRN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 18.01.2008
Dividend Date

Stock Valuation AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 500
Enterprise Value Revenue 0.2391
Price Sales TTM 1.2515
Enterprise Value EBITDA -1.4474
Price Book MRQ 0.6979

Financials AMRN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AMRN

For 52 weeks

0.63 USD 1.49 USD
50 Day MA 0.86 USD
Shares Short Prior Month 16 064 070
200 Day MA 0.92 USD
Short Ratio 15.82
Shares Short 15 809 853
Short Percent 3.96 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds


S

SLICHA

203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics

Metals


Gold

2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics